YEDA - Technology Transfer Company of Weizmann Institute of Science
Fani David-Melnik serves as the Executive Assistant and Head Office at WIN - Weizmann Innovation Nest since November 2023, where responsibilities include overseeing venture creation deal flow in deep tech fields. Previously, Fani held the position of Executive Assistant to the CEO at Yeda - Technology Transfer Company of the Weizmann Institute of Science since October 2020, facilitating horizontal projects within the organization. An extensive background in administrative support is demonstrated through roles at Orbotech, including Operations Administrative Assistant, Personal Assistant to the CFO, and Department Assistant for the PCB division, alongside experience as Executive Assistant to the CEO at Aeronautics Group. Fani holds a Bachelor's degree in Education from Achva Academic College, obtained in 2000.
This person is not in the org chart
This person is not in any teams
YEDA - Technology Transfer Company of Weizmann Institute of Science
Yeda ("Knowledge" in Hebrew) Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science (WIS) and is the second company of its kind established in the world. WIS is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel and Founder of the Institute. Yeda initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by WIS scientists. Yeda holds an exclusive agreement with WIS to market and commercialize its intellectual property and generate income to support further research and education. Since 1959 Yeda has generated the highest income per researcher compared to any other TTO worldwide. Weizmann has generated a number of groundbreaking therapies, such as Copaxone, Rebif, Tookad, Erbitux, Vectibix, Protrazza, Humira, and recently the CAR-T cancer therapy Yescarta. Yeda performs the following activities: ◣ Identifies and assesses research projects with commercial potential. ◣ Protects the intellectual property of WIS and its scientists. ◣ Licenses WIS' inventions and technologies to industry. ◣ Establishes new Startup companies based in WIS Intellectual Property ◣ Channels funding from industry to research projects. Our portfolio covers a broad spectrum of the natural sciences, including: ◣ Agriculture and Plant Genetics, including Bio-fuels ◣ Chemistry and Nanotechnology ◣ Environmental Sciences and Solar Energy ◣ Mathematics and Computer Science ◣ Medical Devices ◣ Pharmaceuticals and Diagnostics ◣ Physics and Electro-Optics ◣ Research Tools